Direct Oral Anticoagulants Market Analysis Report - 2035

Future Market Insights

Direct Oral Anticoagulants Market

Key Insight

The direct oral anticoagulants market is projected to grow from USD 32.4 billion in 2025 to USD 66.8 billion by 2035, at a CAGR of 7.5%. Novel Oral Anticoagulant will dominate with a 64.8% market share, while atrial fibrillation will lead the disease indication segment with a 41.7% share.

July 23, 2025

Anurag Sharma

250 Pages

Cite this Report

Direct Oral Anticoagulants Market

https://www.futuremarketinsights.com/reports/direct-oral-anticoagulants-market

License

Buy Now

Summary ToC Companies

Key Players

Boehringer Ingelheim
Cipla Ltd
Daiichi Sankyo Company
Eisai Co. Ltd
GlaxoSmithKline plc (GSK)
Johnson & Johnson Services
The Vanguard Group
Portola Pharmaceuticals Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Direct Oral Anticoagulants Market

Key Players

Similar Industry Reports